Evaluation of FOXP3 Treg and their Correlation with Heat Shock Protein 90 in Breast Cancer Patients
Al-Iraqia Medical College Journal · 15.04.2026 · 3 (1) · 46-58
DOI: 10.58564/aimcj3.1.2026.138 ↗Kurz gefasst
Fachartikel in der Zeitschrift Al-Iraqia Medical College Journal, online erschienen am 15.04.2026. Verfasst von Tuqa A. Nuaman und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Breast cancer is the most prevalent malignancy among women and one of the leading causes of cancer-related deaths globally. Many individuals are still diagnosed at advanced stages, and its incidence continues to rise due to lifestyle, hormonal, and hereditary factors. The disease is biologically diverse, with molecular subtypes (luminal, HER2-positive, triple-negative) that influence prognosis and therapy. Despite progress in screening and targeted treatments, recurrence and therapy resistance remain major challenges, highlighting the need for new prognostic markers and improved therapeutic strategies. The study aims to evaluate immunological markers to assess the prognostic value of Forkhead Box P3 (FOXP3). Positive Tregs and their correlation with Heat Shock Protein 90 (HSP-90) in breast cancer. This case-control study, conducted over three months (November 2024 to February 2025), included 140 females from the Baghdad Medical City (Oncology Educational Hospital) who underwent a three-milliliter blood aspiration. Participants were divided into two groups; one group consisted of 70 patients with breast cancer, while the other group consisted of 70 apparently healthy people (control group). ELISA measured serum levels of FOXP3 and HSP-90. Participants provided demographic information, including age, sex, family history, and medical history. The study samples ranged in age from 19 to 85 years, with a mean age of 49.86 ± 12.71 years. The majority of the sample (46.4%) was in the 46-60 age range. Women with breast cancer had significantly higher mean values of HSP-90 than the control group (P
Zitieren
APA
Nuaman, T. A., Fahad, H. M., & Shaker, R. M. (2026). Evaluation of FOXP3 Treg and their Correlation with Heat Shock Protein 90 in Breast Cancer Patients. Al-Iraqia Medical College Journal, 3(1), 46-58. https://doi.org/10.58564/aimcj3.1.2026.138
Vancouver
Nuaman TA, Fahad HM, Shaker RM. Evaluation of FOXP3 Treg and their Correlation with Heat Shock Protein 90 in Breast Cancer Patients. Al-Iraqia Medical College Journal. 2026;3(1):46-58. doi:10.58564/aimcj3.1.2026.138
BibTeX
@article{Nuaman2026,
author = {Nuaman, Tuqa A. and Fahad, Hayfaa Mahmood and Shaker, Rafid Munir},
title = {Evaluation of FOXP3 Treg and their Correlation with Heat Shock Protein 90 in Breast Cancer Patients},
journal = {Al-Iraqia Medical College Journal},
year = {2026},
volume = {3},
number = {1},
pages = {46--58},
doi = {10.58564/aimcj3.1.2026.138}
}
EUVIMED